{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Axogen, Inc."},"Symbol":{"label":"Symbol","value":"AXGN"},"Address":{"label":"Address","value":"13631 PROGRESS BOULEVARD,SUITE 400, ALACHUA, Florida, 32615, United States"},"Phone":{"label":"Phone","value":"+1 386 462-6800"},"Industry":{"label":"Industry","value":"Biotechnology: Electromedical & Electrotherapeutic Apparatus"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain."},"CompanyUrl":{"label":"Company Url","value":"https://www.axogeninc.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ivica Ducic","title":"Chief Medical Officer"},{"name":"Michael D. Dale","title":"President, Chief Executive Officer & Director"},{"name":"Stacy Arnold","title":"VP-Product Development & Clinical Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}